Advisornet Financial’s Bioventus BVS Stock Holding History

Advisornet Financial’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-400	Closed	-$6K	–	2031
2021 Q3	$6K	Buy	+400	New	+$6.16K	﹤0.01%	1568

Other funds holding BVS

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Advisornet Financial's BVS Position: Q4 2021 in Review

Advisornet Financial sold out of Bioventus (BVS) in Q4 2021, closing a stake of 400 shares — an estimated $6K sold.

Advisornet Financial first reported a position in BVS in Q3 2021 and held it in 1 quarter. The position peaked at $6K in Q3 2021. 98 funds tracked by Wall St. Rank hold BVS as of Q4 2021.

Advisornet Financial reported no remaining Bioventus position as of Q4 2021 after selling out during the quarter.
Advisornet Financial sold 400 Bioventus shares in Q4 2021, an estimated $6K.
Advisornet Financial first reported a position in Bioventus in Q3 2021 and held it in 1 quarter.
Advisornet Financial's Bioventus position peaked at $6K in Q3 2021.
98 funds tracked by Wall St. Rank held Bioventus as of Q4 2021.

Based on Advisornet Financial's 13F filing for Q4 2021, filed 19 Jan 2022.